Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1959 2
1960 1
1961 4
1963 3
1964 1
1965 3
1967 2
1968 9
1969 7
1970 7
1971 9
1972 2
1973 3
1974 3
1975 10
1976 7
1977 6
1978 10
1979 7
1980 14
1981 20
1982 17
1983 19
1984 20
1985 28
1986 17
1987 24
1988 24
1989 45
1990 41
1991 39
1992 58
1993 43
1994 50
1995 59
1996 58
1997 86
1998 59
1999 70
2000 87
2001 93
2002 81
2003 85
2004 98
2005 107
2006 100
2007 104
2008 110
2009 98
2010 101
2011 73
2012 104
2013 104
2014 103
2015 121
2016 101
2017 133
2018 136
2019 116
2020 134
2021 158
2022 138
2023 115
2024 143
2025 142
2026 41

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,463 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hamada h[Author] (2,008 results)?
Japan-Multimodal Intervention Trial for the Prevention of Dementia: A randomized controlled trial.
Sakurai T, Sugimoto T, Akatsu H, Doi T, Fujiwara Y, Hirakawa A, Kinoshita F, Kuzuya M, Lee S, Matsumoto N, Matsuo K, Michikawa M, Nakamura A, Ogawa S, Otsuka R, Sato K, Shimada H, Suzuki H, Suzuki H, Takechi H, Takeda S, Uchida K, Umegaki H, Wakayama S, Arai H; J‐MINT study group. Sakurai T, et al. Among authors: shimada h. Alzheimers Dement. 2024 Jun;20(6):3918-3930. doi: 10.1002/alz.13838. Epub 2024 Apr 22. Alzheimers Dement. 2024. PMID: 38646854 Free PMC article. Clinical Trial.
Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases.
Endo H, Ono M, Takado Y, Matsuoka K, Takahashi M, Tagai K, Kataoka Y, Hirata K, Takahata K, Seki C, Kokubo N, Fujinaga M, Mori W, Nagai Y, Mimura K, Kumata K, Kikuchi T, Shimozawa A, Mishra SK, Yamaguchi Y, Shimizu H, Kakita A, Takuwa H, Shinotoh H, Shimada H, Kimura Y, Ichise M, Suhara T, Minamimoto T, Sahara N, Kawamura K, Zhang MR, Hasegawa M, Higuchi M. Endo H, et al. Among authors: shimada h. Neuron. 2024 Aug 7;112(15):2540-2557.e8. doi: 10.1016/j.neuron.2024.05.006. Epub 2024 Jun 5. Neuron. 2024. PMID: 38843838 Free article.
Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Bagatell R, Park JR, Acharya S, Aldrink J, Allison J, Alva E, Arndt C, Benedetti D, Brown E, Cho S, Church A, Davidoff A, Desai AV, DuBois S, Fair D, Farinhas J, Harrison D, Huang F, Iskander P, Kreissman S, Macy M, Na B, Pashankar F, Pendyala P, Pinto N, Polites S, Rabah R, Shimada H, Slatnick L, Sokol E, Twist C, Vo K, Watt T, Wolden S, Zage P, Schonfeld R, Hang L. Bagatell R, et al. Among authors: shimada h. J Natl Compr Canc Netw. 2024 Aug;22(6):413-433. doi: 10.6004/jnccn.2024.0040. J Natl Compr Canc Netw. 2024. PMID: 39151455
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, Tanaka H, Azekawa S, Mikami Y, Lee H, Hasegawa T, Okudela K, Okuzaki D, Motooka D, Kanai M, Naito T, Yamamoto K, Wang QS, Saiki R, Ishihara R, Matsubara Y, Hamamoto J, Hayashi H, Yoshimura Y, Tachikawa N, Yanagita E, Hyugaji T, Shimizu E, Katayama K, Kato Y, Morita T, Takahashi K, Harada N, Naito T, Hiki M, Matsushita Y, Takagi H, Aoki R, Nakamura A, Harada S, Sasano H, Kabata H, Masaki K, Kamata H, Ikemura S, Chubachi S, Okamori S, Terai H, Morita A, Asakura T, Sasaki J, Morisaki H, Uwamino Y, Nanki K, Uchida S, Uno S, Nishimura T, Ishiguro T, Isono T, Shibata S, Matsui Y, Hosoda C, Takano K, Nishida T, Kobayashi Y, Takaku Y, Takayanagi N, Ueda S, Tada A, Miyawaki M, Yamamoto M, Yoshida E, Hayashi R, Nagasaka T, Arai S, Kaneko Y, Sasaki K, Tagaya E, Kawana M, Arimura K, Takahashi K, Anzai T, Ito S, Endo A, Uchimura Y, Miyazaki Y, Honda T, Tateishi T, Tohda S, Ichimura N, Sonobe K, Sassa CT, Nakajima J, Nakano Y, Nakajima Y, Anan R, Arai R, Kurihara Y, Harada Y, Nishio K, Ueda T, Azuma M, Saito R, Sado T, Miyazaki Y, Sato R, Haruta Y, Nagasaki T, Yasui Y, Hasegawa Y, Mutoh Y, Kimura T, Sato T, Takei R, Hagimoto S,… See abstract for full author list ➔ Namkoong H, et al. Among authors: shimada h. Nature. 2022 Sep;609(7928):754-760. doi: 10.1038/s41586-022-05163-5. Epub 2022 Aug 8. Nature. 2022. PMID: 35940203 Free PMC article.
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations.
Sembill S, Ampatzidou M, Chaudhury S, Dworzak M, Kalwak K, Karow A, Kiani A, Krumbholz M, Luesink M, Naumann-Bartsch N, De Moerloose B, Osborn M, Schultz KR, Sedlacek P, Giona F, Zwaan CM, Shimada H, Versluijs B, Millot F, Hijiya N, Suttorp M, Metzler M. Sembill S, et al. Among authors: shimada h. Leukemia. 2023 Mar;37(3):505-517. doi: 10.1038/s41375-023-01822-2. Epub 2023 Jan 27. Leukemia. 2023. PMID: 36707619 Free PMC article. Review.
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, Marshall L, Chesler L, Granger M, Desai AV, Mody R, Morgenstern DA, Shusterman S, Macy ME, Pinto N, Schleiermacher G, Vo K, Thurm HC, Chen J, Liyanage M, Peltz G, Matthay KK, Berko ER, Maris JM, Marachelian A, Mossé YP. Goldsmith KC, et al. Among authors: shimada h. Nat Med. 2023 May;29(5):1092-1102. doi: 10.1038/s41591-023-02297-5. Epub 2023 Apr 3. Nat Med. 2023. PMID: 37012551 Free PMC article. Clinical Trial.
[Esophageal Foreign Body].
Suzuki T, Shimada H. Suzuki T, et al. Among authors: shimada h. Kyobu Geka. 2022 Sep;75(10):895-900. Kyobu Geka. 2022. PMID: 36155589 Japanese.
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma.
Ménard M, Yoda H, Nasholm N, Barata MJ, Wang L, Simonds EF, Lu ED, Wong-Michalak S, McHenry L, Farrel A, Kaufman R, Lopez V, Kennedy RJ, Fernandez GE, Shimada H, Grossmann LD, Asgharzadeh S, Maris JM, Gustafson WC, Weiss WA. Ménard M, et al. Among authors: shimada h. J Exp Med. 2025 Sep 1;222(9):e20231417. doi: 10.1084/jem.20231417. Epub 2025 Jul 14. J Exp Med. 2025. PMID: 40658105 Free PMC article.
3,463 results